登录    注册    忘记密码    使用帮助

详细信息

In vivo assessment of the probiotic potentials of three host -associated Bacillus species on growth performance, health status and disease resistance of Oreochromis niloticus against Streptococcus agalactiae  ( SCI-EXPANDED收录)   被引量:29

文献类型:期刊文献

英文题名:In vivo assessment of the probiotic potentials of three host -associated Bacillus species on growth performance, health status and disease resistance of Oreochromis niloticus against Streptococcus agalactiae

作者:Kuebutornye, Felix K. A.[1,2,3,4,5,6];Tang, Jufen[1,3,6];Cai, Jia[1,3,6];Yu, Huang[1,3,6];Wang, Zhiwen[1,2,3,4,5,6];Abarike, Emmanuel Delwin[7];Lu, Yishan[1,2,3,4,5,6];Li, Yuan[1,2,3,4,5,6];Afriyie, Gyamfua[8]

机构:[1]Guangdong Ocean Univ, Coll Fisheries, Zhanjiang 524088, Guangdong, Peoples R China;[2]Guangdong Ocean Univ, Shenzhen Inst, Shenzhen 518120, Guangdong, Peoples R China;[3]Prov Key Lab Pathogen Biol & Epidemiol Aquat Anim, Zhanjiang 524088, Peoples R China;[4]Guangdong Prov Engn Res Ctr Aquat Anim Hlth Asses, Shenzhen 518120, Peoples R China;[5]Shenzhen Publ Serv Platform Evaluat Marine Econ A, Shenzhen 518120, Peoples R China;[6]Guangdong Key Lab Control Dis Aquat Econ Anim, Zhanjiang 524088, Peoples R China;[7]Univ Dev Studies, Dept Fisheries & Aquat Resources Management, Tamale, Ghana;[8]Guangdong Ocean Univ, Fisheries Coll, Key Lab Aquaculture South China Sea Aquat Econ An, Guangdong Higher Educ Inst, Zhanjiang 524025, Peoples R China

年份:2020

卷号:527

外文期刊名:AQUACULTURE

收录:SCI-EXPANDED(收录号:WOS:000539995500020)、、Scopus(收录号:2-s2.0-85084555777)、WOS

基金:Shenzhen strategic emerging and future industrial development funds (20170426231005389) supported this work.

语种:英文

外文关键词:Bacillus; Gene expression; Immunity; Nile tilapia; Probiotics; S. agalactiae

外文摘要:Four weeks feeding trial was conducted to assess the in vivo probiotic potentials of three host-associated Bacillus species in O. niloticus. The fish were divided into five treatment groups and fed with diets containing no bacteria (group CT), B. velezensis TPS3N (group V), B. subtilis TPS4 (group S), B. amyloliquefaciens TPS17 (group A) and a 5th group which comprised the combination of the three Bacillus species at a ratio 1:1:1 (group CB). At the end of the feeding trial, enhanced growth performance in terms of final weight (FW), weight gain (WG), specific growth rate (SGR) as well as significantly lower (P < .05) feed conversion ratio (FCR) were recorded in the Bacillus treatment groups with the CB group having the best performance. Improved immune and biochemical (P < .05) (nitric oxide (NO), immunoglobulin M (IgM), lysozyme (LZM), acid phosphatase (ACP), and alkaline phosphatase (AKP)) indexes, antioxidant enzymes (superoxide dismutase (SOD) and catalase (CAT)) and digestive enzymes (lipase and trypsin) were also recorded in the treatment groups relative to the CT group. Significantly lower (P < .05) GOT and MDA activities were also observed in the V, S, A, and CB groups than the CT groups. Growth-related genes GHR-1 and IGF-1 were upregulated significantly (P < .05) in both liver and head kidney (HK) of fish fed Bacillus supplemented diets. Likewise, the CB group induced significant upregulation (P < .05) of TNF-α, TLR-2, IgM (except in the liver) and C-LYZ in both liver and HK. A subsequent challenge test with S. agalactiae resulted in cumulative mortalities (%) of 60%, 33%, 27%, 20%, and 13% in the CT, V, S, A, and CB treatment groups respectively. It was therefore concluded from this experiment that dietary inclusion of the Bacillus species singularly or in combination could elicit probiotic effects and protect O. niloticus against S. agalactiae infection. ? 2020

参考文献:

正在载入数据...

版权所有©广东海洋大学 重庆维普资讯有限公司 渝B2-20050021-8 
渝公网安备 50019002500408号 违法和不良信息举报中心